# Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, Article 57

Extent: E+W+S+N.I.

Notwithstanding Article 60, Member States may require the use of certain forms of labelling of the medicinal product making it possible to ascertain:
the price of the medicinal product,
the reimbursement conditions of social security organizations,
the legal status for supply to the patient, in accordance with Title VI,
authenticity and identification in accordance with Article 54a(5).
For medicinal products authorised under Regulation (EC) No 726/2004, Member States shall, when applying this Article, observe the detailed guidance referred to in Article 65 of this Directive.

---
Source: https://www.legislation.gov.uk/eudr/2001/83/article/57 (the official version)
Page: https://openlegislation.uk/eu-directive-2001-83/article-57
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.